Abstract
Seven heterocyclic compounds derived from isatin have been synthesized. Isatin was N-substituted with four aromatic/aliphatic and benzylic moieties (1a-d). Compounds 1a-c were condensed with o-phenylenediamine to afford indoloquinoxaline derivatives (2a-c). Products were tested as inhibitors of InhA enzyme of M. tuberculosis. Compound 6-(diethylaminoethyl)indoloquinoxaline (2a) inhibited 38% of InhA activity at 50 µM. The possible modes of interaction of 2a with InhA were explored by molecular docking. Docking experiments afford keys to improve compound 2a for the design of new potential active drugs against tuberculosis.
Keywords: Heterocyclic compounds, InhA inhibition, modeling, tuberculosis.
Letters in Organic Chemistry
Title:Synthesis of an Indoloquinoxaline Derivative as Potential Inhibitor of InhA enzyme of Mycobacterium tuberculosis
Volume: 12 Issue: 10
Author(s): Asmae Zanzoul, Aurélien Chollet, Estefania Piedra-Arroni, Jean-Luc Stigliani, Vania Bernardes-Génisson, El Mokhtar Essassi and Geneviève Pratviel
Affiliation:
Keywords: Heterocyclic compounds, InhA inhibition, modeling, tuberculosis.
Abstract: Seven heterocyclic compounds derived from isatin have been synthesized. Isatin was N-substituted with four aromatic/aliphatic and benzylic moieties (1a-d). Compounds 1a-c were condensed with o-phenylenediamine to afford indoloquinoxaline derivatives (2a-c). Products were tested as inhibitors of InhA enzyme of M. tuberculosis. Compound 6-(diethylaminoethyl)indoloquinoxaline (2a) inhibited 38% of InhA activity at 50 µM. The possible modes of interaction of 2a with InhA were explored by molecular docking. Docking experiments afford keys to improve compound 2a for the design of new potential active drugs against tuberculosis.
Export Options
About this article
Cite this article as:
Zanzoul Asmae, Chollet Aurélien, Piedra-Arroni Estefania, Stigliani Jean-Luc, Bernardes-Génisson Vania, Essassi El Mokhtar and Pratviel Geneviève, Synthesis of an Indoloquinoxaline Derivative as Potential Inhibitor of InhA enzyme of Mycobacterium tuberculosis, Letters in Organic Chemistry 2015; 12 (10) . https://dx.doi.org/10.2174/1570178612666150924000909
DOI https://dx.doi.org/10.2174/1570178612666150924000909 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Porphyrins in Photodynamic Therapy - A Search for Ideal Photosensitizers
Current Medicinal Chemistry - Anti-Cancer Agents Antitubercular Marine Natural Products
Current Medicinal Chemistry Isothiouronium Salts Reduce NRAS Expression, Induce Apoptosis and Decrease Invasion of Melanoma Cells
Anti-Cancer Agents in Medicinal Chemistry Predicting Experimental Properties of Proteins from Sequence by Machine Learning Techniques
Current Protein & Peptide Science New Perspectives of Infections in Cardiovascular Disease
Current Cardiology Reviews Sepsis and Solid Organ Transplantation
Current Drug Targets Microwave-Assisted Synthesis and Bioactivities of Novel Quinoline Lactones
Letters in Organic Chemistry Integrating Virtual Screening and Combinatorial Chemistry for Accelerated Drug Discovery
Combinatorial Chemistry & High Throughput Screening Recent Developments in Oral Bait Vaccines for Wildlife
Recent Patents on Drug Delivery & Formulation Vitamin D and Acute Respiratory Tract Infection
Current Respiratory Medicine Reviews Novel Therapeutic Agents for Resistant Gram-Positive Infections
Current Drug Therapy Biological Activities of Quinoline Derivatives
Mini-Reviews in Medicinal Chemistry The Evolution of Extensively Drug Resistant Tuberculosis (XDR-TB): History, Status and Issues for Global Control
Infectious Disorders - Drug Targets Lipid-based Nanocarriers Loaded with Taxanes for the Management of Breast Cancer: Promises and Challenges
Current Drug Targets Recent Development of Coumarin Derivatives as Potential Antiplasmodial and Antimalarial Agents
Current Topics in Medicinal Chemistry Discrimination of Chemical Profiles of Some Bacterial Species by Analyzing Culture Headspace Air Samples Using TD-GC/MS
Current Analytical Chemistry Reviving an Old HIV-1 Gene: The HIV-1 Antisense Protein
Current HIV Research Advances of Phenoxazines: Synthesis, Reactivity and Their Medicinal Applications
Current Medicinal Chemistry Meet Our Editorial Board Member:
Current Medicinal Chemistry Subject Index To Volume 8
Protein & Peptide Letters